Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery

NAUnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

February 28, 2011

Conditions
Breast Cancer
Interventions
DRUG

pegylated liposomal doxorubicin hydrochloride

GENETIC

DNA methylation analysis

GENETIC

TdT-mediated dUTP nick end labeling assay

GENETIC

fluorescence in situ hybridization

GENETIC

loss of heterozygosity analysis

GENETIC

polymerase chain reaction

OTHER

immunoenzyme technique

OTHER

immunohistochemistry staining method

OTHER

laboratory biomarker analysis

PROCEDURE

breast duct lavage

PROCEDURE

neoadjuvant therapy

PROCEDURE

therapeutic conventional surgery

Trial Locations (2)

90403

RECRUITING

Doctor Susan Love Research Foundation, Santa Monica

95501

RECRUITING

St. Joseph Hospital, Eureka

All Listed Sponsors
lead

Dr. Susan Love Research Foundation

OTHER